Phage therapy News and Research

RSS

Study finds new clues for disarming antibiotic-resistant bacteria

A virus can stop bacteria from sharing genes for antibiotic resistance among themselves, Texas A&M AgriLife researchers have discovered. The results hint at new ways to treat infections and describe a new feature of a highly diverse, largely unexplored part of the biosphere.

3 Nov 2020

Scientists use experimental approach to identify genes and interactions

A phage is a virus that invades a bacterial cell. While harmless to human cells, phages are potentially deadly to bacteria since many phages enter a cell in order to hijack its machinery in order to reproduce itself, thus destroying the cell.

28 Oct 2020

Study finds unique viral 'fingerprint' for each human gut

Each person's gut virus composition is as unique as a fingerprint, according to the first study to assemble a comprehensive database of viral populations in the human digestive system.

24 Aug 2020

Standardized guidelines for phage therapy can speed up lifesaving treatment

When clinicians resort to phage therapy for patients who don't respond to antibiotics, the patients are usually very ill and time is of the essence. But the average time for labs to produce therapeutic phages is more than a month.

17 Aug 2020

Researchers show usefulness of potential 'phage cocktail' therapy on wound infections

Australian researchers have shown how viruses can be used to save lives, developing the potential use of bacteriophages in bandages to treat life-threatening golden staph infections which may not respond to traditional antibiotics.

30 Jul 2020

Bacteriophages may play a key role in treating prosthetic joint infections

Bacteriophages, or phages, may play a significant role in treating complex bacterial infections in prosthetic joints, according to new Mayo Clinic research.

24 Jul 2020

Bacteriophage could help decrease mortality of patients with COVID-19

Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up. This could decrease the mortality of patients affected by COVID-19, according to the peer-reviewed journal PHAGE: Therapy, Applications, and Research.

24 Jun 2020

Research explores how COVID-19 is spreading and mutating in the environment

A multi-disciplinary team of experts in virology and computer modeling has quickly assembled at San Diego State University to learn more about how the new coronavirus (COVID-19) spreads in the environment and how its trajectory can be better predicted.

13 May 2020

Researchers discover previously unknown anti-phage defense mechanism in certain bacteria

Researchers from Singapore-MIT Alliance for Research and Technology, MIT’s research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

7 May 2020

New anti-phage defense mechanism in bacteria protects their DNA, finds study

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

6 May 2020

Research sheds new light on the phage therapy history

In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, even save lives. Such viruses, phages, infect bacteria.

27 Mar 2020

A controlled phage therapy to target drug-resistant pathogens

The fight against drug-resistant pathogens remains an intense one. While the Centers for Disease Control's 2019 "biggest threats" report reveals an overall decrease in drug-resistant microbe-related deaths as compared to its previous report (2013) the agency also cautions that new forms of drug-resistant pathogens are still emerging.

13 Jan 2020

Researchers discover how a new immune system works to protect bacteria from phages

Researchers at University of California San Diego School of Medicine have discovered how a new immune system works to protect bacteria from bacteriophages (phages), viruses that specifically infect bacteria.

11 Jan 2020

Study shows potential of phage therapy to treat alcoholic liver disease

Bacteriophages (phages) are viruses that specifically destroy bacteria. In the early 20th century, researchers experimented with phages as a potential method for treating bacterial infections.

13 Nov 2019

Researchers use phage therapy to successfully treat alcoholic liver disease

Researchers have successfully used bacteriophage (phage) therapy to eliminate alcohol-related liver disease in an animal model.

13 Nov 2019

Researchers produce synthetic phages that attack broader range of bacterial strains

Bacteriophages ("phages" for short) are viruses that infect bacteria. Phages are highly host-specific and will typically only infect and kill an individual species or even subspecies of bacteria. Compared to conventional antibiotics, phages do not indiscriminately kill bacteria.

4 Nov 2019

Bacteriophage can have a profound impact on the dynamics of gut microbiome, study finds

The gut microbiome is a complex, interconnected ecosystem of species. And, like any ecosystem, some organisms are predators and some are prey.

7 Jun 2019

British teenager with life-threatening infection successfully treated with phage therapy

Doctors report success after treating a British teenager with bacteriophages. The case study is a step forward in the fight against antibiotic resistance.

9 May 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.

9 Jan 2019